UK's Genus soars on US FDA nod for gene-edited pigs

Genus

30/04/2025 09:02

** Britain's Genus GNS.L jumps nearly 30% to 2,055p; top gainer on FTSE mid-cap index .FTMC

** The animal genetics firm says U.S. FDA approves PRP (PRRS resistant pig) gene edit for use in the U.S. food supply chain

** "US approval is crucial in moving to commercialisation, so this is a seminal moment for Genus," Peel Hunt analysts say

** Including session's gains, stock up ~25% YTD

 (Reporting by DhanushVignesh Babu in Bengaluru)

 ((DhanushVignesh.Babu@thomsonreuters.com;))